Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Geoffrey Guittard

8PUBLICATIONS
38CO-AUTHORS
Haematological tumoursMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

Sort by Publication Date:
|Sep 20, 2024
Targeting BTN2A1 Enhances Vγ9Vδ2 T-Cell Effector Functions and Triggers Tumor Cell Pyroptosis.

Anne-Charlotte Le Floch, Caroline Imbert, Nicolas Boucherit

|Jul 02, 2024
DOK1 and DOK2 regulate CD8 T cell signaling and memory formation without affecting tumor cell killing.

Vladimir Laletin, Pierre-Louis Bernard, Camille Montersino

|May 25, 2023
Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors.

Clémence Demerlé, Laurent Gorvel, Marielle Mello

|May 22, 2023
Negative intracellular regulators of T-cell receptor (TCR) signaling as potential antitumor immunotherapy targets.

Vladimir Laletin, Pierre-Louis Bernard, Cathy Costa da Silva

|Jul 27, 2022
CISH Expression Is Associated with Metastasis-Free Interval in Triple-Negative Breast Cancer and Refines the Prognostic Value of PDL1 Expression.

Laurys Boudin, Alexandre De Nonneville, Pascal Finetti

|May 19, 2022
Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity.

Pierre-Louis Bernard, Rebecca Delconte, Sonia Pastor

Pageof 2

Frequent Collaborators

5 joint publications

Jacques Nunes

3 joint publications

Daniel Olive

2 joint publications

Laurent Gorvel

1 joint publications

Mathieu Frechin

1 joint publications

Patricia M Day

1 joint publications

David E Hamm

1 joint publications

Barney S Graham

1 joint publications

Stéphane J C Mancini

1 joint publications

Estelle Duprez

1 joint publications

Rebecca Delconte

Frequent Collaborators

5 joint publications

Jacques Nunes

3 joint publications

Daniel Olive

2 joint publications

Laurent Gorvel

1 joint publications

Mathieu Frechin

Top Related Videos

<em>Ex vivo</em> Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
07:20

<em>Ex vivo</em> Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on : Jan 14, 2011

14.7K
Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8<sup>+</sup> T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8<sup>+</sup> T Cell Responses

Published on : May 06, 2019

9.0K
Using the BLT Humanized Mouse as a Stem Cell based Gene Therapy Tumor Model
06:59

Using the BLT Humanized Mouse as a Stem Cell based Gene Therapy Tumor Model

Published on : Dec 18, 2012

18.8K
See more related videos

Top Related Videos

<em>Ex vivo</em> Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
07:20

<em>Ex vivo</em> Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on : Jan 14, 2011

14.7K
Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8<sup>+</sup> T Cell Responses
10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8<sup>+</sup> T Cell Responses

Published on : May 06, 2019

9.0K
Using the BLT Humanized Mouse as a Stem Cell based Gene Therapy Tumor Model
06:59

Using the BLT Humanized Mouse as a Stem Cell based Gene Therapy Tumor Model

Published on : Dec 18, 2012

18.8K
See more related videos